Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 26, 2026 08:02 ET | Source: Sixty Degrees Pharmaceuticals

60 Degrees Pharmaceuticals Announces Early Enrollment of First Seasonal Patient in Clinical Trial of Tafenoquine for Patients Hospitalized with Babesiosis

60 Degrees Pharma enrolls first 2026 babesiosis trial patient ahead of schedule, supporting possible early interim analysis.